In the short term they would certainly gain a premium on their investment, that's for sure.
However, not seeing the entire project reaching fruition and being operational as a production going concern, then no.
You would possibly be better off taking a position in the other member(s) of the JV agreement, especially as it's basically paid for in cash earned from their current activities.
Hopefully I'm entirely misled in my assumption and the board have plans away from the current JV, due to different external market forces instead.
- Forums
- ASX - By Stock
- CCM
- Ann: Commencement of Third Joint HPA Extended Pilot Plant Trial
Ann: Commencement of Third Joint HPA Extended Pilot Plant Trial, page-22
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CCM (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.3¢ |
Change
0.001(1.61%) |
Mkt cap ! $23.36M |
Open | High | Low | Value | Volume |
6.4¢ | 6.9¢ | 6.2¢ | $12.63K | 195.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 189270 | 6.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.6¢ | 36438 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 189270 | 0.063 |
1 | 64769 | 0.062 |
2 | 35000 | 0.060 |
1 | 80000 | 0.059 |
1 | 8000 | 0.058 |
Price($) | Vol. | No. |
---|---|---|
0.066 | 36438 | 1 |
0.067 | 130000 | 1 |
0.069 | 86206 | 3 |
0.070 | 110013 | 4 |
0.071 | 3000 | 1 |
Last trade - 13.13pm 15/07/2024 (20 minute delay) ? |
Featured News
CCM (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online